Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

bleomycin; n/a; regeneration; antitumor efficacy; lung cancer; SOX2; leiomyosarcoma; lung cancer (LC); nanoparticles; cytokines; hepatocellular carcinoma; metabolic reprogramming; hepatic stellate cells; angiogenesis; transforming growth factor-?; anaplastic lymphoma kinase; idiopathic pulmonary fibrosis; growth factor; pathogenesis; cancer-associated fibroblasts; fibrosis; lipopolysaccharide; DHA; lncRNA; SREBP-1; YAP; protein S; non-small cell lung cancer (NSCLC); omega-3 fatty acid; inflammation; metastasis; clinical symptoms; miRNA; smooth muscle tumor of uncertain malignant potential; Wnt; interstitial fluid pressure; heterogeneity; hepatocytes; myometrium; tumor necrosis factor ?; tumor; tumor microenvironment; extracellular matrix; TAZ; carcinogenesis; cystic formation; pulmonary fibrosis; HBV; cytokine; genetic instability; diagnosis; EMT; crizotinib; Hippo pathway; GPR120; marker; HCV; non-alcoholic steatohepatitis; pathology; common pathways; apoptosis; type I collagen; GPR40; acute lung injury; uterine fibroid; renal injury; pathophysiology; reactive oxygen species; immunohistochemistry; SMAD; butylidenephthalide; leiomyoma; cirrhosis; Erk1/2; targeted therapy; TGF-?; mechanotransduction; therapy; breast cancer; hepatocellular carcinoma (HCC); hepatic stellate cells (HSCs); idiopathic pulmonary fibrosis (IPF); cancer-associated fibroblasts (CAFs); cancer; signal pathway; tumor stiffness